Ryvu Therapeutics Sa

This study is testing a new drug called MEN1703, both by itself and combined with another drug (glofitamab), for people with aggressive B-cell lymphoma that has come back or hasn't responded to at least two prior treatments. It aims to see if these treatments are safe and can hel…

This study is testing a new drug called RVU120, both alone and combined with an existing medication (ruxolitinib), for adults with intermediate or high-risk myelofibrosis. The goal is to see if these treatments can reduce spleen size, improve symptoms, and control the disease in …